These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34624752)

  • 21. Light-responsive hyaluronic acid nanomicelles co-loaded with an IDO inhibitor focus targeted photoimmunotherapy against "immune cold" cancer.
    Wu C; Xu J; Xie Z; Huang H; Li N; Wei X; Li T; Yang H; Li S; Qin X; Liu Y
    Biomater Sci; 2021 Nov; 9(23):8019-8031. PubMed ID: 34718362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy.
    Guo Y; Liu Y; Wu W; Ling D; Zhang Q; Zhao P; Hu X
    Biomaterials; 2021 Sep; 276():121018. PubMed ID: 34284200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
    Zhou L; Zhang P; Wang H; Wang D; Li Y
    Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-Delivery Photo-Immune Stimulators for Photodynamic Sensitized Tumor Immunotherapy.
    Zhao LP; Zheng RR; Huang JQ; Chen XY; Deng FA; Liu YB; Huang CY; Yu XY; Cheng H; Li SY
    ACS Nano; 2020 Dec; 14(12):17100-17113. PubMed ID: 33236625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Injectable Micelle-Incorporated Hydrogels for the Localized Chemo-Immunotherapy of Breast Tumors.
    Qin X; He L; Feng C; Fan D; Liang W; Wang Q; Fang J
    ACS Appl Mater Interfaces; 2021 Oct; 13(39):46270-46281. PubMed ID: 34550685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogrammed IDO-Induced Immunosuppressive Microenvironment Synergizes with Immunogenic Magnetothermodynamics for Improved Cancer Therapy.
    Wang X; Yan B; Li H; Yuan J; Guo J; Wang S; Dai P; Liu X
    ACS Appl Mater Interfaces; 2024 Jun; 16(24):30671-30684. PubMed ID: 38843203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy.
    Choi J; Park B; Park JY; Shin D; Lee S; Yoon HY; Kim K; Kim SH; Kim Y; Yang Y; Shim MK
    Adv Mater; 2024 Sep; 36(38):e2405475. PubMed ID: 38898702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modularly Designed Peptide Nanoprodrug Augments Antitumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2,3-Dioxygenase.
    Han X; Cheng K; Xu Y; Wang Y; Min H; Zhang Y; Zhao X; Zhao R; Anderson GJ; Ren L; Nie G; Li Y
    J Am Chem Soc; 2020 Feb; 142(5):2490-2496. PubMed ID: 31944687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Microenvironment-Specific Driven Nanoagents for Synergistic Mitochondria Damage-Related Immunogenic Cell Death and Alleviated Immunosuppression.
    Qian Y; Chen W; Wang M; Xie Y; Qiao L; Sun Q; Gao M; Li C
    Small Methods; 2024 Jul; 8(7):e2301231. PubMed ID: 38126694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GSH-Responsive Metal-Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy.
    Du L; He H; Xiao Z; Xiao H; An Y; Zhong H; Lin M; Meng X; Han S; Shuai X
    Small; 2022 Apr; 18(15):e2107732. PubMed ID: 35218310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Weichselbaum RR; Lin W
    J Am Chem Soc; 2016 Sep; 138(38):12502-10. PubMed ID: 27575718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomimetic Nanophotosensitizer Amplifies Immunogenic Pyroptosis and Triggers Synergistic Cancer Therapy.
    Wang Q; Qin W; Qiao L; Gao M; Zhou M; Zhang H; Sun Q; Yao W; Yang T; Ren X; Sun G; He X
    Adv Healthc Mater; 2023 Nov; 12(29):e2301641. PubMed ID: 37548137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Han X; Li H; Zhou D; Chen Z; Gu Z
    Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
    Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
    Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
    Yao D; Wang Y; Bian K; Zhang B; Wang D
    Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
    Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
    ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondria-targeted photodynamic therapy triggers GSDME-mediated pyroptosis and sensitizes anti-PD-1 therapy in colorectal cancer.
    Zhou Y; Zhang W; Wang B; Wang P; Li D; Cao T; Zhang D; Han H; Bai M; Wang X; Zhao X; Lu Y
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38429070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An albumin-bound drug conjugate of paclitaxel and indoleamine-2,3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy.
    Hu Z; Zheng B; Xu J; Gao S; Lu W
    Nanotechnology; 2020 May; 31(29):295101. PubMed ID: 32203949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies.
    Wang W; Zhang L; Sun Z
    Cancer Biol Med; 2022 Jul; 19(7):948-64. PubMed ID: 35856558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sialic Acid-Functionalized Pyroptosis Nanotuner for Epigenetic Regulation and Enhanced Cancer Immunotherapy.
    Hu J; You Y; Zhu L; Zhang J; Song Y; Lu J; Xu X; Wu X; Huang X; Xu X; Du Y
    Small; 2024 Mar; 20(10):e2306905. PubMed ID: 37880861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.